Literature DB >> 26412665

Protein Assembly in Serum and the Differences from Assembly in Buffer.

John J Hill1, Thomas M Laue2.   

Abstract

This chapter illustrates how analytical ultracentrifugation methods, coupled with the fluorescence detection system, are an excellent approach to characterizing and comparing protein-binding interactions in dilute solution and concentrated, crowded solutions like serum. We show that in serum, the binding and assembly states for a pair of endogenous protein ligands and an antibody inhibitor are dramatically different than those observed in dilute, simple buffers. This type of analysis approach may be helpful in research efforts intent at discerning the underpinnings to a therapeutic's activity and pharmacokinetic properties in vivo.
© 2015 Elsevier Inc. All rights reserved.

Keywords:  Analytical ultracentrifugation; Antibody; Assembly; Binding; Clusters; Concentrated solution; Confined; Crowded; Fluorescence detection system; Osteoprotegerin; RANKL; Sedimentation velocity; Serum

Mesh:

Substances:

Year:  2015        PMID: 26412665     DOI: 10.1016/bs.mie.2015.06.012

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

1.  Sedimentation of Reversibly Interacting Macromolecules with Changes in Fluorescence Quantum Yield.

Authors:  Sumit K Chaturvedi; Huaying Zhao; Peter Schuck
Journal:  Biophys J       Date:  2017-04-11       Impact factor: 4.033

Review 2.  Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies.

Authors:  Susumu Uchiyama; Masanori Noda; Elena Krayukhina
Journal:  Biophys Rev       Date:  2017-12-14

3.  Resuspending samples in analytical ultracentrifugation.

Authors:  Leonardo M Schuck; Huaying Zhao
Journal:  Anal Biochem       Date:  2020-05-11       Impact factor: 3.365

4.  Monochromatic multicomponent fluorescence sedimentation velocity for the study of high-affinity protein interactions.

Authors:  Huaying Zhao; Yan Fu; Carla Glasser; Eric J Andrade Alba; Mark L Mayer; George Patterson; Peter Schuck
Journal:  Elife       Date:  2016-07-20       Impact factor: 8.140

Review 5.  Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.

Authors:  D S Collins; L C Kourtis; N R Thyagarajapuram; R Sirkar; S Kapur; M W Harrison; D J Bryan; G B Jones; J M Wright
Journal:  Pharm Res       Date:  2017-07-13       Impact factor: 4.200

6.  Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments.

Authors:  Elena Krayukhina; Masanori Noda; Kentaro Ishii; Takahiro Maruno; Hirotsugu Wakabayashi; Minoru Tada; Takuo Suzuki; Akiko Ishii-Watabe; Masahiko Kato; Susumu Uchiyama
Journal:  MAbs       Date:  2017-03-03       Impact factor: 5.857

7.  Measuring macromolecular size distributions and interactions at high concentrations by sedimentation velocity.

Authors:  Sumit K Chaturvedi; Jia Ma; Patrick H Brown; Huaying Zhao; P Schuck
Journal:  Nat Commun       Date:  2018-10-24       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.